Navigation Links
Christopher & Dana Reeve Foundation Commends President Obama's Decision to Lift Federal Restrictions on Stem Cell Research
Date:3/9/2009

SHORT HILLS, N.J., March 9 /PRNewswire-USNewswire/ -- The Christopher & Dana Reeve Foundation joins millions of Americans today in commending President Obama for lifting previous restrictions on federal funding of human embryonic stem cell research.

Peter T. Wilderotter, president and CEO of the Reeve Foundation, stated, "With a stroke of his pen, President Obama acknowledged the will of the majority of Americans and harnessed the power of the federal government to move research forward. By removing politics from science, President Obama has freed researchers to explore these remarkable stem cells, learn from them and possibly develop effective therapies using them. We are extremely gratified for President Obama's action on this important issue."

Wilderotter continued, "Christopher and Dana Reeve's passionate advocacy for federally funded human embryonic stem cell research grew out of their objective understanding of their immense therapeutic potential. The Reeves' public campaign to advance the responsible exploration of all types of stem cells helped create a groundswell of support that continues to grow today. The Reeves' belief in the promise of stem cell research is a part of their lasting legacy."

"The Reeve Foundation adds its voice to those of the many other research institutions, organizations and scientists who laud President Obama for relaxing the August 2001 guidelines," Wilderotter concluded.

Human embryonic stem cells have potential for finding effective regenerative therapies for many diseases and medical conditions. Scientists are using them to better understand how humans develop and what happens in the course of injury and disease. They can also be used to test and screen new drugs.

About the Reeve Foundation

The Christopher & Dana Reeve Foundation is dedicated to curing spinal cord injury by funding innovative research, and improving the quality of life for people living with paralysis through grants, information and advocacy. For more information, and to review the entire list of Quality of Life grant recipients, please visit our website at www.ChristopherReeve.org or call 800-225-0292.

**Note To Editors: This release is being issued in advance of the signing of the Executive Order, which is scheduled for this morning at 11:00 AM. Note Peter Wilderotter, President and CEO of the Christopher & Dana Reeve Foundation, will be representing the Foundation at the White House event.


'/>"/>
SOURCE The Christopher and Dana Reeve Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. St. Christophers Foundation For Children Ronald McDonald(R) Care Mobile Making Tri-State Visits to Provide Dental Care to Children at No Cost
2. Christopher and Dana Reeve Foundation Lauds U.S. House of Representatives Passage of the Christopher and Dana Reeve Paralysis Act
3. COLORBLENDS to Donate Portion of Sales of Spring Forward Daffodil Blend to the Christopher and Dana Reeve Foundation
4. Christopher Reeve Honored as Heroes Hero By CNN
5. Hahnemann University Hospital and St. Christophers Hospital for Children Receive Prestigious Tenet Circle of Excellence Award
6. Hahnemann University Hospital and St. Christophers Hospital for Children Extend Current Agreement With Independence Blue Cross
7. XTENT Appoints Christopher M. Smith and Arthur T. Taylor to Board of Directors
8. Matthew Reeve to Host The Christopher and Dana Reeve Foundations Annual Hamptons Summer Soiree
9. Chicago Artist Tadeusz Seidel Supports Christopher & Dana Reeve Foundation Chicago Chapter Benefit
10. Christopher & Dana Reeve Foundation Launches First-Ever National Advertising Campaign
11. AmericInn Hotels Partners With Nationally Recognized Sleep Expert Dr. Christopher Drake, Announces Launch of Sleep Better America Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... VA (PRWEB) , ... February 12, 2016 , ... ... Feb. 29, 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... in the life cycle of pharmaceutical products, garnering increased attention from all stakeholders ...
(Date:2/12/2016)... ... ... Coco Libre, the maker of coconut water beverages with a purpose, is ... Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut Water, a ... suite, held this year at the W Hollywood Hotel, has become a pre-show “must” ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... (WaaS), today announced the integration of Clarity Intelligence Platform (CIP) into Cielo®, a ... offer real-time business intelligence (BI) to their small and medium business (SMB) clients. ...
(Date:2/12/2016)... ... 2016 , ... AssureVest Insurance Group, a locally owned insurance firm with offices ... raise funds earmarked to purchase computers and software for Mrs. Harrison’s 2nd and 3rd ... in a low-income area and has more than 60 2nd and 3rd graders with ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Erlanger Agency has ... greater Columbus, OH area. The latest campaign focuses on the fight against breast cancer, ... are now being accepted here . , Carmen is a loving single mother ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... -- Eli Lilly and Company (NYSE: LLY ) today announced ... vitamin regimen patent would not presently be infringed by Actavis ... , Italy and Spain ... dextrose solution.  --> --> ... held that Lilly,s patent would be indirectly infringed by Actavis ...
(Date:2/12/2016)... , 12 februari 2016 ... een toonaangevende leverancier van productie en ontwikkeling ... industrieën, kondigt vandaag een uitbreiding aan van ... haar locatie in Charleston, SC ... geleid tot meerdere recente investeringen. ...
(Date:2/12/2016)... Maharashtra, February 12, 2016 ... report titled Chronic Inflammation Global Clinical Trials Review, ... of the global clinical trials landscape along with ... by Region, Country (G7 & E7), Trial Status, ... and reviews top companies involved and enlists all ...
Breaking Medicine Technology: